DR info

臨床試験数 : 4 / 薬物数 : 10 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 11

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Bezafibrate
   Rigshospitalet, Denmark
      2009   Phase 2   NCT00983788   Denmark;
Bezafibrate (drug)
   Assistance Publique - Hôpitaux de Paris
      2006   Phase 3   NCT00336167   France;
Break in L-carnitine treatment
   Karen Lindhardt Madsen
      2013   -   NCT02226419   -
Glycerol/Saline
   Oregon Health and Science University
      2016   -   NCT02517307   United States;
Hyperinsulinemic euglycemic clamp
   Oregon Health and Science University
      2016   -   NCT02517307   United States;
Intralipid/Heparin
   Oregon Health and Science University
      2016   -   NCT02517307   United States;